Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation

Oncogene volume 20, pages 5431–5439 (2001)Cite this article

Abstract

It has recently been shown that the high-risk human papillomavirus (HPV) E6 proteins can target the PDZ-domain containing proteins, Dlg, MUPP-1, MAGI-1 and hScrib for proteasome-mediated degradation. However, the E6 proteins from HPV-16 and HPV-18 (the two most common high-risk virus types) differ in their ability to target these proteins in a manner that correlates with their malignant potential. To investigate the underlying mechanisms for this, we have mutated HPV-16 and HPV-18 E6s to give each protein the other's PDZ-binding motif. Analysis of these mutants shows that the greater ability of HPV-18 E6 to bind to these proteins and to target them for degradation is indeed due to a single amino acid difference. Using a number of assays, we show that the E6 proteins interact specifically with only one of the five PDZ domains of MAGI-1, and this is the first interaction described for this particular PDZ domain. We also show that the guanylate kinase homology domain and the regions of MAGI-1 downstream of amino acid 733 are not required for the degradation of MAGI-1. Finally, in a series of comparative analyses, we show that the degradation of MAGI-1 occurs through a different mechanism from that used by the E6 protein to induce the degradation of Dlg and p53.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Banks L, Matlashewski G, Crawford L . 1986 Eur. J. Biochem. 159: 529–534

  • Bilder D, Li M, Perrimon N . 2000 Science 289: 113–116

  • Craven S, Bredt D . 1998 Cell 93: 495–498

  • Crook T, Tidy J, Vousden K . 1991a Cell 67: 547–556

  • Crook T, Wrede D, Vousden KH . 1991b Oncogene 6: 873–875

  • Dobrosotskaya I, Guy R, James G . 1997 J. Biol. Chem. 272: 31589–31597

  • Dobrosotskaya I, James G . 2000 Biochem. Biophys. Res. Commun. 270: 903–909

  • Downward J . 1998 Curr. Opin. Cell Biol. 10: 262–267

  • Fanning A, Anderson J . 1999 J. Clin. Invest. 103: 767–772

  • Franke T, Kaplan D, Cantley L, Toker A . 1997 Science 275: 665–668

  • Gardiol D, Banks L . 1998 J. Gen. Virol. 79: 1963–1970

  • Gardiol D, Kühne C, Glaunsinger B, Lee S, Javier R, Banks . 1999 Oncogene 18: 5487–5496

  • Glaunsinger B, Lee S, Thomas M, Banks L, Javier R . 2000 Oncogene 19: 5270–5280

  • Gomperts S . 1996 Cell 84: 659–662

  • Gross-Mesilaty S, Reinstein E, Bercovich B, Tobias K, Schwartz A, Kahana C, Ciechanover A . 1998 Proc. Natl. Acad. Sci. USA 95: 8058–8063

  • Huibregtse J, Scheffner M, Howley P . 1991 EMBO. J. 10: 4129–4135

  • Huibregtse J, Scheffner M, Howley P . 1993 Mol. Cell. Biol. 13: 775–784

  • Ide N, Hata Y, Nishioka H, Hirao K, Yao I, Deguchi M, Mizoguchi A, Nishimori H, Tokino T, Nakamura Y, Takai Y . 1999 Oncogene 18: 7810–7815

  • Kim E, DeMarco S, Marfatia S, Chishti A, Sheng M, Strehler E . 1998 J. Biol. Chem. 273: 1591–1595

  • Kim S . 1997 Curr. Opin. Cell Biol. 9: 853–859

  • Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M . 1997 Proc. Natl. Acad. Sci. USA 94: 11612–11616

  • Klippel A, Reinhard C, Kavanaugh W, Apell G, Escobedo M, Williams L . 1996 Mol. Cell Biol. 16: 4117–4127

  • Lee S, Weiss R, Javier R . 1997 Proc. Natl. Acad. Sci. USA 94: 6670–6675

  • Lee S, Glaunsinger B, Mantovani F, Banks L, Javier R . 2000 J. Virol. 74: 9680–9693

  • Li J, Simpson L, Takahashi M, Miliaresis C, Myers M, Tonks N, Parsons R . 1998 Cancer Res. 56: 5667–5672

  • Li X, Coffino P . 1996 J. Virol. 70: 4509–4516

  • Marte B, Downward J . 1997 Trends Biochem. Sci. 22: 355–358

  • Marte B, Rodriguez-Vinciana P, Wennstrom S, Warne P, Downward J . 1997 Curr. Biol. 7: 63–70

  • Mietz J, Unger T, Huibregtse J, Howley P . 1992 EMBO J. 11: 5013–5020

  • Mitic L, Anderson J . 1998 Annu. Rev. Physiol. 60: 121–142

  • Nakagawa S, Huibregtse J . 2000 Mol. Cell Biol. 21: 8244–8253

  • Patrie KM, Drescher AJ, Goyal M, Wiggins RC, Margolis B . 2001 J. Am. Soc. Nephrol. 12: 667–677

  • Pim D, Storey A, Thomas M, Massimi P, Banks L . 1994 Oncogene 9: 1869–1876

  • Pim D, Thomas M, Javier R, Gardiol D, Banks L . 2000 Oncogene 19: 719–725

  • Polakis P . 1999 Curr. Opin. Genet. Dev. 9: 15–21

  • Ponting C, Phillips C . 1995 Trends Biochem. Sci. 20: 102–103

  • Saras J, Heldin C . 1996 Trends Biochem. Sci. 21: 455–458

  • Scheffner M, Werness B, Huibregtse J, Levine A, Howley P . 1990 Cell 63: 1129–1136

  • Scheffner M, Munger K, Byrne JC, Howley PM . 1991 Proc. Natl. Acad. Sci. USA 88: 5523–5527

  • Songyang Z, Fanning A, Fu C, Xu J, Marfatia S, Chisti A, Crompton A, Chan A, Anderson J, Cantley L . 1997 Science 275: 73–77

  • Stambolic V, Suzuki A, de al Pompa J, Brothers G, Mirtsos C, Sasaki T, Ruland J, Penninger J, Siderovski D, Mak T . 1998 Cell 95: 29–39

  • Tashiro H, Blazes M, Wu R, Cho K, Bose S, Wang S, Li J, Parsons R, Ellenson L . 1997 Cancer Res. 57: 3935–3940

  • Thomas M, Banks L . 1998 Oncogene 17: 2943–2954

  • Thomas M, Banks L . 1999 J. Gen. Virol. 80: 1513–1517

  • Thomas M, Massimi P, Jenkins J, Banks L . 1995 Oncogene 10: 261–268

  • Weiss R, Gold M, Vogel H, Javier R . 1997 J. Virol. 71: 4385–4394

  • Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye M, Yuan X, Wood J, Ross C, Sawyers C, Whang Y . 2000a Proc. Natl. Acad. Sci. USA 97: 4233–4238

  • Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Laskey L . 2000b J. Biol. Chem. 275: 21477–21485

Download references

Acknowledgements

This work was supported in part by a grant from the Associazione Italiana per Ricerca sul Cancro to L Banks and grant number RO1 CA58541 from the National Institutes of Health to R Yavier.

Author information

Authors and Affiliations

  1. International Centre for Genetic Engineering and Biotechnology, Padriciano 99, Trieste, I-34012, Italy

    Miranda Thomas, David Pim & Lawrence Banks

  2. Division of Molecular Virology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, Texas, USA

    Britt Glaunsinger & Ron Javier

Authors
  1. Miranda Thomas
    View author publications

    Search author on:PubMed Google Scholar

  2. Britt Glaunsinger
    View author publications

    Search author on:PubMed Google Scholar

  3. David Pim
    View author publications

    Search author on:PubMed Google Scholar

  4. Ron Javier
    View author publications

    Search author on:PubMed Google Scholar

  5. Lawrence Banks
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, M., Glaunsinger, B., Pim, D. et al. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene 20, 5431–5439 (2001). https://doi.org/10.1038/sj.onc.1204719

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1204719

Keywords

This article is cited by

Search

Advanced search

Quick links